Summary
44 / 100 · Bulios Score
What speaks for it
- You pay 15.4 EUR for 1 EUR of yearly profit, little for its sector.
- The 2.6% dividend yield is well covered: it takes 40% of profit.
What to watch
- Revenue fell by 18% a year over the last 3 years.
- It missed profit estimates 5 times in the last 8 quarters.
- It earns only 4.8 EUR a year on every 100 EUR of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.4 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue fell by 8.8% a year over 5 years. Over the last 3 years it fell by 18% a year. For the next fiscal year analysts expect revenue to grow by 3.4%. Earnings per share fell by 16% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 EUR of revenue goes
- Cost of sales 75 EUR
- Research and development 2.8 EUR
- Sales and administration 13 EUR
- Taxes and other 3.1 EUR
- Net profit 6.5 EUR
Net profit, industry median (Medical - Care Facilities) 6.8 EUR
Out of every 100 EUR of revenue, 6.5 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.9 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 2.61%
- Paid out of profit
- 40%
You receive $1.22 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.